LONDON, UNITED KINGDOM--(Marketwire - January 21, 2008) - NextGen Bioscience, Inc. (“NextGen”) (NASDAQ: NXGBE), a biotechnology company that develops novel therapeutic proteins that disrupt the advance of life-threatening cancers, today announced that Dr. Rolf Witte of Germany is joining its Scientific Advisory Board.
